Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 12, 2019 - Issue 10
Submit an article Journal homepage
306
Views
11
CrossRef citations to date
0
Altmetric
Review

What is novel in the clinical management of pemphigus

A. BilgicAntalya Training and Research Hospital, Dermatology Clinic, University of Health Sciences, Antalya, TurkeyORCID Iconhttps://orcid.org/0000-0001-7910-7908View further author information
ORCID Icon &
D. F. MurrellSt George Hospital, Department of Dermatology, University of New South Wales, Sydney, Australia;Faculty of Medicine, University of New South Wales, Sydney, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2971-0199View further author information
ORCID Icon
Pages 973-980 | Received 24 Jul 2019, Accepted 17 Sep 2019, Published online: 29 Sep 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Soheil Tavakolpour, Zeinab Aryanian, Farnoosh Seirafianpour, Milad Dodangeh, Ifa Etesami, Maryam Daneshpazhooh, Kamran Balighi, Hamidreza Mahmoudi & Azadeh Goodarzi. (2021) A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns. Immunopharmacology and Immunotoxicology 43:5, pages 507-518.
Read now

Articles from other publishers (10)

Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh, Zeinab Aryanian & Azadeh Goodarzi. (2023) A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy. Experimental Dermatology 32:7, pages 934-944.
Crossref
Elham Mazaherpour, Nika Kianfar, Shayan Dasdar, Mojtaba Sedaghat, Hassan Seyrafi, Kamran Balighi, Fatemeh Saberi, Ali Nili, Zeinab Farimani, Pedram Molhem Azar, Hamidreza Mahmoodi, Dedee F. Murrell & Maryam Daneshpazhooh. (2022) Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab‐treated and rituximab‐naïve patients. Dermatologic Therapy 35:12.
Crossref
Nika Kianfar, Shayan Dasdar, Hamidreza Mahmoudi & Maryam Daneshpazhooh. (2022) Burden of pemphigus vulgaris with a particular focus on women: A review. International Journal of Women’s Dermatology 8:3, pages e056.
Crossref
Michelle K. Y. Chen, Ravi Vissapragada, Norma Bulamu, Monisha Gupta, Victoria Werth & Deshan Frank Sebaratnam. (2022) Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris. JAMA Dermatology 158:9, pages 1013.
Crossref
Faith A.P. Zeng & Dedee F. Murrell. (2021) State‐of‐the‐art review of human autoimmune blistering diseases (AIBD). Veterinary Dermatology 32:6, pages 524.
Crossref
Wenzhe Zhao, Jingying Wang, Haiqin Zhu & Meng Pan. (2021) Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies. Clinical Reviews in Allergy & Immunology 61:3, pages 351-362.
Crossref
Roberto MAGLIE, Emiliano ANTIGA & Aimee S. PAYNE. (2021) B-cell targeted therapies in pemphigus. Italian Journal of Dermatology and Venereology 156:2.
Crossref
Kossara Drenovska, Snejina Vassileva, Ivan Tanev & Pascal Joly. (2021) Impact of COVID-19 on autoimmune blistering diseases. Clinics in Dermatology 39:3, pages 359-368.
Crossref
Po-Yuan Wu, Te-Mao Li, Shu-I. Chen, Chao-Jung Chen, Jian-Shiun Chiou, Ming-Kuem Lin, Fuu-Jen Tsai, Yang-Chang Wu, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Yu-Ning Lin, Wen-Miin Liang & Ying-Ju Lin. (2020) Complementary Chinese Herbal Medicine Therapy Improves Survival in Patients With Pemphigus: A Retrospective Study From a Taiwan-Based Registry. Frontiers in Pharmacology 11.
Crossref
A. Di Altobrando, A. Patrizi & F. Bardazzi. (2020) Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases?. Journal of the European Academy of Dermatology and Venereology 34:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.